Israeli biotech phenom puts death knell on cancer

Israeli biotech phenom puts death knell on cancer.?At 44, Gal Markel is a biotech bulldozer. After a $95 million exit, the professor of immunology serves as the Deputy Director General of Beilinson Hospital and the Director of the Davidoff Cancer Center, and is also involved in five startups. Now he has raised around $33 million to establish the Samueli Institute, researching ways to help the immune system eradicate cancer cells.

"Israel was the first to emerge from the pandemic, but will be the last to emerge from the global tech crisis.”?Sivan Shamri Dahan, Managing Partner of Qumra Capital, was speaking at a special conference in the Knesset led by high-tech industry organizations opposing the judicial overhaul. "If 10,000-20,000 high-tech workers leave Israel there will no longer be a high-tech industry here,” noted Professor Eugene Kandel.

"Our mission is to turn the State of Israel into an AI superpower."?Defense Ministry director-general Eyal Zamir also revealed that steps to harness rapid AI evolutions include the formation of a dedicated organization for military robotics in the ministry, and a record-high budget for related research and development this year.

Google’s new passkeys will require more than your fingerprint to keep you safe.?The threat to your information is still rampant despite a new era of password protection, says Perception Point CTO.

Opinion |?Are down rounds the new layoffs??"With 2023 shaping up to be the year of down rounds, what is the potential impact on the Israeli tech ecosystem, and how can founders avoid being part of this trend?" writes Eyal Bino, Founding Partner of 97212 Ventures.